Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update. [electronic resource]
Producer: 19930901Description: 27-31; quiz 32 p. digitalISSN:- 0093-7754
- Adolescent
- Adult
- Antineoplastic Agents -- therapeutic use
- Bone Marrow Transplantation -- adverse effects
- Busulfan -- administration & dosage
- Child
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Female
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- mortality
- Male
- Middle Aged
- Morbidity
- Premedication
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.